A radical new approach to the treatment of paralysis, muscle weakness and spasticity

PathMaker Neurosystems is a clinical-stage neurotechnology company founded to commercialize recent breakthrough advances in the development of non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders. We are focused on rapidly bringing to market a revolutionary approach to non-invasively treating conditions such as paralysis, muscle weakness and spasticity found in patients with stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson’s disease and other neurological disorders. Based on extensive published studies and breakthrough human results, the Company is advancing an entirely novel treatment paradigm based on coordinated multi-site neurostimulation. Modulation of neural activity is accomplished through precisely sequenced non-invasive stimulation at multiple body sites, enabled by directionally-controllable spinal level modulation using trans-spinal Direct Current Stimulation (tsDCS).

Caution: The products discussed on this website are investigational medical
devices and are limited by US Federal law to investigational use only.